Development of a vaccine for celiac disease

Pediatric and Adolescent Medicine

Volumn 12, Issue , 2008, Pages 172-180

  Anderson, R P ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870160264     PISSN: 10175989     EISSN: 16623886     Source Type: Book Series    
DOI: 10.1159/000129030     Document Type: Article

References (42)

1. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT: Longterm clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-475. (Pubitemid 29372886)
2. Oldfield WL, Larche M, Kay AB: Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomized controlled trial. Lancet 2002;360:47-53. (Pubitemid 34756492)
3. Sollid LM, Khosla C: Future therapeutic options for celiac disease. Nat Clin Pract Gastroenterol Hepatol 2005;2:140-147. (Pubitemid 40812513)
4. Larche M, Wraith DC: Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005;11:S69-S76. (Pubitemid 40562306)
5. Verhoef A, Alexander C, Kay AB, Larche M: T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Med 2005;2:e78.
6. Haselden BM, Kay AB, Larche M: Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 1999;189:1885-1894. (Pubitemid 29295887)
7. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KE, Sjostrom H, Sollid LM: Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Medicine 1998;4:713-717 (Pubitemid 28274673)
8. (erratum appears in Nat Med 1998;4:974).
9. Ali FR, Oldfield WL, Higashi N, Larche M, Kay AB: Late asthmatic reactions induced by inhalation of allergenderived T cell peptides. Am J Respir Crit Care Med 2004;169:20-26. (Pubitemid 38233884)
10. Lanzavecchia A, Sallusto F: Understanding the generation and function of memory T cell subsets. Curr Opin Immunol 2005;17:326-332. (Pubitemid 40692670)
11. Alexander C, Ying S, Kay AB, Larche M: Fel d 1-derived T cell peptide therapy induces recruitment of CD4+CD25+; CD4+interferongamma + T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects. Clin Exp Allergy 2005;35:52-58. (Pubitemid 40188270)
12. Strickland DH, Stumbles PA, Zosky GR, Subrata LS, Thomas JA, Turner DJ, Sly PD, Holt PG: Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+regulatory T cells. J Exp Med 2006;203:2649-2660. (Pubitemid 44833341)
13. Jones EY, Fugger L, Strominger JL, Siebold C: MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 2006;6:271-282.
14. *0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993;178:187-196. (Pubitemid 23173254)
15. Lundin KE, Scott H, Fausa O, Thorsby E, Sollid LM: T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol 1994;41:285-291.
16. Halstensen TS, Brandtzaeg P: Activated T lymphocytes in the celiac lesion: nonproliferative activation (CD25) of CD4+ alpha/beta cells in the lamina propria but proliferation (Ki-67) of alpha/beta and gamma/delta cells in the epithelium. Eur J Immunol 1993;23:505-510. (Pubitemid 23075085)
17. Halstensen TS, Scott H, Fausa O, Brandtzaeg P: Gluten stimulation of celiac mucosa in vitro induces activation (CD25) of lamina propria CD4+ T cells and macrophages but no cryptcell hyperplasia. Scand J Immunol 1993;38:581-590. (Pubitemid 24002044)
18. Freedman AR, Macartney JC, Nelufer JM, Ciclitira PJ: Timing of infiltration of T lymphocytes induced by gluten into the small intestine in celiac disease. J Clin Pathol 1987;40:741-745. (Pubitemid 17094590)
19. Arentz-Hansen H, Korner R, Molberg O, Quarsten H, Vader W, Kooy YM, Lundin KE, Koning F, Roepstorff P, Sollid LM, McAdam SN: The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000;191:603-612.
20. Quarsten H, McAdam SN, Jensen T, Arentz-Hansen H, Molberg O, Lundin KE, Sollid LM: Staining of celiac diseaserelevant T cells by peptide-DQ2 multimers. J Immunol 2001;167:4861-4868. (Pubitemid 33009714)
21. Vader W, Kooy Y, Van Veelen P, De Ru A, Harris D, Benckhuijsen W, Pena S, Mearin L, Drijfhout JW, Koning F: The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 2002;122:1729-1737. (Pubitemid 34651415)
22. Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C: Structural basis for gluten intolerance in celiac sprue. Science 2002;297:2275-2279.
23. Qiao SW, Bergseng E, Molberg O, Jung G, Fleckenstein B, Sollid LM: Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation. J Immunol 2005;175:254-261. (Pubitemid 40884326)
24. Arentz-Hansen H, McAdam SN, Molberg O, Fleckenstein B, Lundin KE, Jorgensen TJ, Jung G, Roepstorff P, Sollid LM: Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002;123:803-809. (Pubitemid 34977086)
25. Vader LW, Stepniak DT, Bunnik EM, Kooy YM, de Haan W, Drijfhout JW, Van Veelen PA, Koning F: Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 2003;125:1105-1113. (Pubitemid 37193457)
26. *0201) heterodimer. Hum Immunol 1994;39:243-252.
27. Sturgess R, Day P, Ellis HJ, Lundin KE, Gjertsen HA, Kontakou M, Ciclitira PJ: Wheat peptide challenge in celiac disease. Lancet 1994;343:758-761. (Pubitemid 24098692)
28. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, Picard J, Osman M, Quaratino S, Londei M: Association between innate response to gliadin and activation of pathogenic T cells in celiac disease. Lancet 2003;362:30-37. (Pubitemid 36835817)
29. Sjostrom H, Lundin KE, Molberg O, Korner R, McAdam SN, Anthonsen D, Quarsten H, Noren O, Roepstorff P, Thorsby E, Sollid LM: Identification of a gliadin T-cell epitope in celiac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol 1998;48:111-115. (Pubitemid 28365999)
30. Molberg O, McAdam S, Lundin KE, Kristiansen C, Arentz-Hansen H, Kett K, Sollid LM: T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol 2001;31:1317-1323. (Pubitemid 32454680)
31. Caruso R, Fina D, Peluso I, Stolfi C, Fantini MC, Gioia V, Caprioli F, Del Vecchio Blanco G, Paoluzi OA, Macdonald TT, Pallone F, Monteleone G: A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells. Gastroenterology 2007;132:166-175. (Pubitemid 46108732)
32. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM: CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 1999;162:186-194. (Pubitemid 29018919)
33. Peluso I, Fantini MC, Fina D, Caruso R, Boirivant M, MacDonald TT, Pallone F, Monteleone G: IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol 2007;178:732-739. (Pubitemid 46095145)
34. Gjertsen HA, Sollid LM, Ek J, Thorsby E, Lundin KE: T cells from the peripheral blood of celiac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol 1994;39:567-574. (Pubitemid 24217149)
35. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV: In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000;6:337-342. (Pubitemid 30148628)
36. Ben-Horin S, Green PH, Bank I, Chess L, Goldstein I: Characterizing the circulating, gliadin-specific CD4+ memory T cells in patients with celiac disease: linkage between memory function, gut homing and Th1 polarization. J Leukoc Biol 2006;79:676-685. (Pubitemid 44835600)
37. Raki M, Fallang LE, Brottveit M, Bergseng E, Quarsten H, Lundin KE, Sollid LM: Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc Natl Acad Sci USA 2007;104:2831-2836. (Pubitemid 46327965)
38. Anderson RP, van Heel DA, Tye-Din JA, Barnardo M, Salio M, Jewell DP, Hill AV: T cells in peripheral blood after gluten challenge in celiac disease. Gut 2005;54:1217-1223. (Pubitemid 41192478)
39. Beissbarth T, Tye-Din JA, Smyth GK, Speed TP, Anderson RP: A systematic approach for comprehensive T-cell epitope discovery using peptide libraries. Bioinformatics 2005;21(suppl 1):i29-37. (Pubitemid 41794472)
40. Tye-Din JA, Beissbarth T, Anderson RP: A comprehensive bioinformatic and functional screen of wheat gluten T-cell epitopes in HLA-DQ2 celiac disease in vivo. Gastroenterology 2005;128:A-2.
41. Tye-Din JA, Beissbarth T, Anderson RP: T-cell epitope hierarchy after rye and barley ingestion in celiac disease. Gastroenterology 2005;128:A-259.
42. Tye-Din JA, Beissbarth T, Anderson RP: A 35mer peptide with T cell stimulatory activity comparable to whole gliadin: a lead compound for peptide immunotherapy in celiac disease? Gastroenterology 2006;130:A-95.